Zobrazeno 1 - 10
of 41
pro vyhledávání: '"David M. Marks"'
Autor:
Chi-Un Pae, David M. Marks, Ashwin A. Patkar, Manan J. Shah, Geun-Young Park, Prakash S. Masand
Publikováno v:
Current Neuropharmacology
The precise mechanisms of pain perception and transmission in the central nervous system have not been fully elucidated. However, extensive data support a role for the monoamine neurotransmitters, serotonin and norepinephrine, in the modulation of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0e5896e716df0ecfb0093fcd820055
https://doi.org/10.2174/157015909790031201
https://doi.org/10.2174/157015909790031201
Autor:
Manan J. Shah, David M. Marks, Chi-Un Pae, Prakash S. Masand, Byung Joo Ham, Ashwin A. Patkar, Changsu Han
Publikováno v:
Clinical Neuropharmacology. 32:355-363
Milnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) with negligible effects on any presynaptic or postsynaptic receptors. Milnacipran has unique pharmacokinetic and pharmacodynamic characteristics that distinguish it from the othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8f0936460e807c0aa7470db5d001de
https://doi.org/10.1097/wnf.0b013e3181ac155b
https://doi.org/10.1097/wnf.0b013e3181ac155b
Autor:
Prakash S. Masand, Chi-Un Pae, Kathleen S. Peindl, Paolo Mannelli, Stan Krulewicz, David M. Marks, Ashwin A. Patkar
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:996-1002
Background Despite of a high comorbidity of depressive and/or anxiety disorders with fibromyalgia, information on the clinical implications of this comorbidity is limited but antidepressants are commonly prescribed to treat fibromyalgia in clinical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c4123bd2a38e3f305069968b7b7f44
https://doi.org/10.1016/j.pnpbp.2009.05.005
https://doi.org/10.1016/j.pnpbp.2009.05.005
Autor:
Prakash S. Masand, Paolo Mannelli, Kathleen S. Peindl, David M. Marks, Patrick E. Ciccone, Changsu Han, Ashwin A. Patkar, Christa Hooper-Wood, Chi-Un Pae
Publikováno v:
Clinical Neuropharmacology. 32:85-88
There are limited data to indicate effective treatment strategies for antidepressant-related sexual dysfunction, in particular for patients with treatment-resistant major depression. We subanalyzed our published data whether augmentation with methylp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134874bb1d7837391413013fb73ca021
https://doi.org/10.1097/wnf.0b013e31817e559b
https://doi.org/10.1097/wnf.0b013e31817e559b
Publikováno v:
Psychiatry Investigation
The classically structured clinical trial does not offer enough flexibility to make use of continuously emerging knowledge that is generated as the trial progresses. In this regard, there are consistent issues impeding effective psychiatric research,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5699caedc91b8ee1aba5a27ff90690c5
http://europepmc.org/articles/PMC2796037
http://europepmc.org/articles/PMC2796037
Autor:
Alessandro Serretti, Prakash S. Masand, Ashwin A. Patkar, Chi-Un Pae, David M. Marks, Laura Mandelli, Tae Suk Kim, David C. Steffens, Changsu Han, Diana De Ronchi
Publikováno v:
Biomedicine & Pharmacotherapy. 63:228-235
The incidence or recurrence of major depression is greatly increased in women during the transition to and after menopause and hormonal changes occurring during these periods are thought to play an important role in depressive recurrence. It has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac788b3ea8df21f6d81861db45b594c
https://doi.org/10.1016/j.biopha.2008.03.010
https://doi.org/10.1016/j.biopha.2008.03.010
Autor:
Ashwin A. Patkar, Kathleen S. Peindl, Chi-Un Pae, David M. Marks, Paolo Mannelli, Changsu Han, Stan Krulewicz, Prakash S. Masand
Publikováno v:
World journal of biological psychiatry, 10(4), 435-441. Taylor & Francis Ltd
Objectives. We conducted a post-hoc analysis to determine whether a history of physical or sexual abuse was associated with response to treatment in a double-blind, randomized, placebo-controlled trial of paroxetine controlled release (CR) in fibromy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc49fe96a0ebbac86f377e0d4b7a5ba9
https://doi.org/10.1080/15622970902789155
https://doi.org/10.1080/15622970902789155
Autor:
Ashwin A. Patkar, Chi-Un Pae, David M. Marks, Byung Joo Ham, Min Hyeon Park, Prakash S. Masand, Changsu Han
Publikováno v:
Expert Opinion on Drug Safety. 7:783-794
Paroxetine is a selective serotonin re-uptake inhibitor (SSRI) available in immediate release and controlled release (CR) formulations. Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. Paroxetine has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761116e5da6eb0a0cc894cc39aa8f0da
https://doi.org/10.1517/14740330802423168
https://doi.org/10.1517/14740330802423168
Publikováno v:
Current Treatment Options in Neurology. 10:386-395
Delirium is a complex neuropsychiatric syndrome presenting primarily with disturbances of cognition, perception and sensorium, alertness, sleep/wake cycle, and psychomotor behavior in the context of a medical etiology. The presentation can be quite v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::609f1e468421043a105a3e31b5189916
https://doi.org/10.1007/s11940-008-0041-x
https://doi.org/10.1007/s11940-008-0041-x
Publikováno v:
Psychiatry Investigation
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075238ce89220220826bda888340f7cb
http://europepmc.org/articles/PMC2796030
http://europepmc.org/articles/PMC2796030